Abstract:Three novel rare earth complexes, [Ln2(DCA)2(phen)2](NO3)2·6H2O (Ln(III)=Sm(III)(1), Er(III)(2), Yb(III)(3); DCA2−=demethylcantharate, 7-oxabicyclo[2.2.1] heptane-2,3-dicarboxylate, C8H8O52−; phen=1,10-phenanthroline, C12H8N2) were synthesized. The structures were characterized by elemental analysis, molar conductance, IR and TGA. The results suggested that the structural features of the complexes were: in each DCA2−, one carboxylate group, as bidentate bridging group, connected two rare earth ions; the other carboxylate group, as bidentate chelate group took part in the coordination with rare earth ion. And cyclic ether oxygen of DCA2− and nitrogen atoms of phen took part in the coordination. The probable coordination number was seven. The interaction of the complexes with DNA was studied by UV-spectra, fluorescence spectra and viscosity measurements. Following increasing the concentration of DNA, the UV absorption bands nearby 265 nm of the three complexes appeared hypochromism and red-shift phenomena. And the values of binding constants Kb were 1.89×105 L/mol (1), 3.54×104 L/mol (2) and 3.83×104 L/mol (3). The complexes could quench the fluorescence of EB-DNA system, and the values of equilibrium constants Ksq were 1.72(1), 0.56(2) and 1.09(3). The relative viscosity of DNA steadily decreased with increasing the concentration of complexes. So, we could infer that the complexes may partially insert into DNA. The study of agarose gel electrophoresis showed that the complexes could cleave plasmid DNA, and the process of the reaction was through unclassical redox mechanism.

Synthesis, Structure Characterization and Anti-Tumor Activity of Lanthanide Complex Ln[ (phen)2 (5-Fu)3 (NO3) ] (NO3)2

Synthesis, characterization and cytotoxicity of lanthanum(III) complexes with novel 1,10-phenanthroline-2,9-bis-α-amino acid conjugates

Two new lanthanide complexes with 5-(Pyrazol-1-yl)nicotinic acid: Structures and their anti-cancer properties

SYNTHESIS AND CHARACTERIZATION OF SCHIFF-BASE COMPLEXES DERIVED FROM SALICYLALDEHYDE-L-TYROSINE AND Ln(NO3)3·6H2O

Synthesis, Crystal Structure And Antitumor Activity Of Mixed Ligand Coordination Compound Of Copper With Norfloxacin And 1,10-Phen, [Cu(Nflx)(Phen)(H2o)] No3 Center Dot 3h(2)O

Synthesis, Characterization and DNA Binding of the Complexes of Rare Earth with Phenanthroline and Demethylcantharate

Synthesis, Characterization, Dna-Binding Studies of Rare Earth Complexes with N-Phenyl Norcantharidin Acylamide Acid

Palladium(II) Complexes with N,N′-Dialkyl-1,10-phenanthroline-2,9-dimathanamine: Synthesis, Characterization and Cytotoxic Activity

Synthesis, Characterization and Antitumor Activity of Lanthanum(Iii) Complex with Demethylcantharidate

Synthesis, Characterization and Antitumor Activity of Lanthanum(Ⅲ) Complex with Demethylcantharidate

Synthesis, structural characterization and antitumor activity of six rare earth metal complexes with 8-hydroxyquinoline derivatives

Two wheel-shaped Pr(III) and Er(III) complexes with long flexible ligand: Crystal structure, fluorescence and anticancer studies

Preparation, crystal structures and properties of a series of novel lanthanide complexes based on 2,3-dimethoxybenzoic acid and 1,10-phenanthroline

Synthesis, Thermodynamic Properties and Antibacterial Activities of Lanthanide Complexes with 3,5-Dimethoxybenzoic Acid and 1,10-Phenanthroline

Synthesis and Anti-tumor Activity of Novel 2-Amino-1,3,4-thiadiazole Derivativers

DNA binding studies and in-vitro anticancer studies of novel lanthanide complexes

Synthesis of 1,10-phenanthroline-erbium(Ⅲ) complex and its biological activity

Synthesis and Characterization of Lanthanide Metal Ion Complexes of New Polydentate Hydrazone Schiff Base Ligand

SYNTHESIS OF COMPLEXES OF 1,10-PHENANTHROLINE WITH RARE EARTH TRIFLUOROACETATE

Synthesis, Crystal Structure and Antitumor Activity of Mixed Ligand Coordination Compound of Copper with Norfloxacin and 1, 10-Phen, [Cu(NFLX)(phen)(H2O)] NO3·3H2O

Investigation of the complex structure, comparative DNA-binding and DNA cleavage of two water-soluble mono-nuclear lanthanum(III) complexes and cytotoxic activity of chitosan-coated magnetic nanoparticles as drug delivery for the complexes